Canterbury DHB


December 2014

don't forget to update the issue and next review variables!!!

Changes in this release

Topic or section

Brief description


Donor Selection Assessment and Consent

Bone marrow donor assessment checklist has been replaced by the Donor Medical Assessment Form and the Stem Cell Donor Questionnaire has been added to the section

Meghan Heaphy

NHL and HD

This section has been reviewed and updated. See the summary of changes for NHL and HD.

Peter Ganly

Idarubicin / Cytarabine Protocol

References to AraC have been changed to Cytarabine

Jenny Roberts

Acute Lymphoblastic Leukaemia

This section has been reviewed and updated. See the summary of changes for Acute Lymphoblastic Leukaemia.

Peter Ganly

SCT Prescription Charts

There are new charts for:

  • Fludarabine, cytarabine, Amsacrine, and IV Busulphan
  • Fludarabine and IV Busulphan
  • Cyclophosphamide and IV Busulphan

Jenny Roberts

Supportive Care Sheets

A link to the NZBS approval form has been added.

Jenny Roberts

Aplastic Anaemia

A more recent review of Aplastic Anaemia has been added to Overview.

Andrew Butler

Relapsed / Refractory Disease

Links to two guidelines (including one for alemtuzumab) were added.

Andrew Butler

Immunosuppression - ATG/ALG and Cyclosporin

Information on Supportive care during immunosuppression administration has been updated.

Jenny Roberts

Multiple Myeloma

Information about the availability of Lenalidomide for compassionate use beyond 3rd line treatment has been added.

Jenny Roberts

Mild Haemophilia

Dosage information for Desmopressin has been updated.

Mark Smith

Jenny Roberts

About this Canterbury DHB document (139909):

Document Owner:

Not assigned (see Who's Who)

Last Reviewed:

Next Review:


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 139909